Triple-negative Breast Cancer
📧 Sign up to get email alerts when something new happens for Triple-negative Breast Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2015-11-05Clinical Trial Update: An Open-Label Multicenter Phase 2 Window of Opportunity Study Evaluating Ganetespib in Women With Breast Cancer [Phase 2]
Open-label Phase 2 window-of-opportunity study evaluating ganetespib in women with breast cancer has completed.
-
CLINICAL_TRIALS trial_result · 2015-11-03Clinical Trial Update: BRCA1-associated DNA Repair Dysfunction in Patients With Early Triple Negative Breast Cancer Treated With Neoadjuvant Platinum-based Chemotherapy [Phase 2]
Phase 2 clinical trial update evaluating BRCA1-associated DNA repair dysfunction in patients with early triple-negative breast cancer treate…
-
CLINICAL_TRIALS trial_result · 2015-10-20Clinical Trial Update: Treatment of Relapsed and/or Chemotherapy Refractory Advanced Malignancies by CART-meso [Phase 1]
Phase 1 study of CART-meso, a mesothelin-targeted CAR-T cell therapy, in patients with relapsed or chemotherapy-refractory advanced cancers,…
-
CLINICAL_TRIALS trial_result · 2015-09-04Clinical Trial Update: Gamma-Secretase/Notch Signalling Pathway Inhibitor RO4929097, Paclitaxel, and Carboplatin Before Surgery in Treating Patients With Stage II or Stage III Triple-Negative Breast Cancer [Phase 1]
Phase 1 trial evaluating RO4929097 with paclitaxel and carboplatin before surgery in stage II/III triple-negative breast cancer was terminat…
-
CLINICAL_TRIALS trial_result · 2015-07-23Clinical Trial Update: Study of High-dose Chemotherapy (HDC) Combined With Adoptive Cellular Therapy With DC-CIK Cells in Triple Negative Breast Cancer Patients
A completed clinical trial evaluating high-dose chemotherapy combined with adoptive dendritic cell-CIK cell therapy in patients with triple-…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2015-05-25Clinical Trial Update: Veliparib in Combination With Carboplatin and Paclitaxel in Treating Patients With Locally Advanced or Metastatic Solid Tumors [Phase 1]
Phase 1 trial update evaluating veliparib in combination with carboplatin and paclitaxel for locally advanced or metastatic solid tumors. Th…
-
CLINICAL_TRIALS trial_result · 2015-04-15Clinical Trial Update: RO4929097 and Vismodegib in Treating Patients With Breast Cancer That is Metastatic or Cannot Be Removed By Surgery [Phase 1]
A phase 1 trial of RO4929097 and vismodegib for metastatic or unresectable breast cancer was terminated; no results are reported in this upd…
-
CLINICAL_TRIALS trial_result · 2015-03-23Clinical Trial Update: Paclitaxel With or Without Carboplatin and/or Bevacizumab Followed by Doxorubicin and Cyclophosphamide in Treating Patients With Breast Cancer That Can Be Removed by Surgery [Phase 2]
A Phase 2 trial evaluating paclitaxel with or without carboplatin and/or bevacizumab, followed by doxorubicin and cyclophosphamide, in patie…
-
CLINICAL_TRIALS trial_result · 2015-03-23Clinical Trial Update: Gemcitabine Plus Cisplatin Versus Gemcitabine Plus Paclitaxel in Triple Negative Breast Cancer (TNBC) [Phase 3]
Phase 3 trial comparing gemcitabine plus cisplatin vs gemcitabine plus paclitaxel in triple-negative breast cancer has completed. The record…
-
CLINICAL_TRIALS trial_result · 2015-02-23Clinical Trial Update: Phase II Study of Capecitabine and Cisplatin to Treat Metastatic Triple Negative Breast Cancer [Phase 2]
Phase II results update for a capecitabine and cisplatin regimen in metastatic triple-negative breast cancer. The results were posted in 201…
-
CLINICAL_TRIALS trial_result · 2015-02-18Clinical Trial Update: Phase II Study With Abraxane, Bevacizumab and Carboplatin in Triple Negative Metastatic Breast Cancer [Phase 2]
Phase II trial of Abraxane, Avastin (bevacizumab), and carboplatin in triple-negative metastatic breast cancer completed; results were poste…
-
CLINICAL_TRIALS trial_result · 2015-02-16Clinical Trial Update: A Study of NK012 in Patients With Advanced, Metastatic Triple Negative Breast Cancer [Phase 2]
Phase 2 trial update of NK012 in advanced, metastatic triple-negative breast cancer has completed enrollment and analysis.
-
CLINICAL_TRIALS trial_result · 2015-02-03Clinical Trial Update: AR-inhibitor Bicalutamide in Treating Patients With TNBC [Phase 2]
Phase 2 trial investigating the AR inhibitor bicalutamide for triple-negative breast cancer; current status is UNKNOWN.
-
CLINICAL_TRIALS trial_result · 2015-01-26Clinical Trial Update: Re-expression of ER in Triple Negative Breast Cancers [Phase 1, Phase 2]
This update reports results from a Phase 1/2 trial evaluating re-expression of the estrogen receptor in triple-negative breast cancer. The s…
-
CLINICAL_TRIALS trial_result · 2014-12-31Clinical Trial Update: Triple Negative Breast Cancer: Study of Molecular and Genetic Factors [NA]
Clinical trial update describing a study of molecular and genetic factors in triple-negative breast cancer; the trial status is unknown.
-
CLINICAL_TRIALS trial_result · 2014-12-17Clinical Trial Update: Neoadjuvant Sunitinib With Paclitaxel/Carboplatin in Patients With Triple-Negative Breast Cancer [Phase 1, Phase 2]
Phase 1/2 trial evaluating neoadjuvant sunitinib combined with paclitaxel and carboplatin in patients with triple-negative breast cancer com…
-
CLINICAL_TRIALS trial_result · 2014-12-15Clinical Trial Update: Panitumumab, Gemcitabine and Carboplatin in Triple-Negative Metastatic Breast Cancer [Phase 2]
Phase 2 trial evaluating panitumumab with gemcitabine and carboplatin in metastatic triple-negative breast cancer; the study has been comple…
-
CLINICAL_TRIALS trial_result · 2014-12-15Clinical Trial Update: Study Of Abraxane® And Carboplatin As First-Line Treatment For Triple Negative Metastatic Breast Cancer [Phase 2]
Phase 2 trial evaluating Abraxane plus carboplatin as first-line therapy for triple-negative metastatic breast cancer was terminated; result…
-
CLINICAL_TRIALS trial_result · 2014-12-02Clinical Trial Update: Additional 4 Cycles of Cisplatin (CDDP4) in Patients With Triple Negative Breast Cancer for Neoadjuvant Chemotherapy [Phase 2]
A Phase 2 trial update exploring the addition of four cycles of cisplatin (CDDP4) as neoadjuvant chemotherapy for patients with triple-negat…
-
CLINICAL_TRIALS trial_result · 2014-11-13Clinical Trial Update: Study of NK012 and Carboplatin in Solid Tumors With Dose Expansion in Triple Negative Breast Cancer [Phase 1]
Phase 1 study of NK012 in combination with carboplatin in advanced solid tumors with dose expansion in metastatic triple-negative breast can…
-
CLINICAL_TRIALS trial_result · 2014-11-05Clinical Trial Update: Induction Preoperative Chemotherapy for Patients With Locally Advanced Triple Negative Breast Cancer [Phase 2]
Phase 2 clinical trial evaluating induction preoperative chemotherapy for locally advanced triple-negative breast cancer has completed.
-
CLINICAL_TRIALS trial_result · 2014-09-04Clinical Trial Update: A Clinical Trial Comparing Gemcitabine and Carboplatin With and Without P276-00 in Subjects With Metastatic Triple Negative Breast Cancer, With a Run-in of Escalating Dose of P276-00 Added to Gemcitabine and Carboplatin [Phase 1]
A Phase 1 trial comparing gemcitabine and carboplatin with or without the investigational agent P276-00 in metastatic triple-negative breast…
-
CLINICAL_TRIALS trial_result · 2014-04-15Clinical Trial Update: Phase II Study of Carboplatin and Bevacizumab (Avastin) for ER Neg, PR Neg, and HER2/Neu Neg Metastatic Breast Cancer [Phase 2]
Phase II trial of carboplatin plus bevacizumab for triple-negative metastatic breast cancer; the study was terminated and results were poste…
-
CLINICAL_TRIALS trial_result · 2014-01-14Clinical Trial Update: Study of SAR240550 (BSI-201) in Combination With Gemcitabine/Carboplatin, in Patients With Metastatic Triple Negative Breast Cancer [Phase 2]
Completed Phase 2 trial evaluating SAR240550 (BSI-201) in combination with gemcitabine and carboplatin for metastatic triple-negative breast…
-
CLINICAL_TRIALS trial_result · 2013-09-30Clinical Trial Update: 7-Hydroxystaurosporine and Irinotecan Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors or Triple Negative Breast Cancer (Currently Accruing Only Triple-negative Breast Cancer Patients Since 6/8/2007) [Phase 1]
This Phase 1 clinical trial update evaluates the combination of 7-Hydroxystaurosporine and Irinotecan Hydrochloride in patients with metasta…